vs
和黄医药（HCM）与Purple Innovation, Inc.（PRPL）财务数据对比。点击上方公司名可切换其他公司
和黄医药的季度营收约是Purple Innovation, Inc.的1.9倍（$270.8M vs $140.7M），和黄医药净利率更高（0.7% vs -2.3%，领先3.0%），Purple Innovation, Inc.同比增速更快（9.1% vs -16.5%），和黄医药自由现金流更多（$3.4M vs $-7.8M）
和黄医药是一家国际化生物制药企业，专注于肿瘤、免疫类疾病的靶向疗法与免疫疗法的研发、生产及商业化，核心市场覆盖中国及全球多个国家地区，已有多款肿瘤治疗药物上市，后期临床管线储备丰富。
Purple Carrot是一家总部位于马萨诸塞州尼达姆市的全植物性餐包品牌，由安迪·莱维特创立，每周为订阅用户提供预制餐品和自制餐包。据《大都会》2022年报道，对比美式标准餐食，该品牌每份餐包的碳排放量可降低72%，主打低碳环保的纯植物饮食方案。
HCM vs PRPL — 直观对比
营收规模更大
HCM
是对方的1.9倍
$140.7M
营收增速更快
PRPL
高出25.6%
-16.5%
净利率更高
HCM
高出3.0%
-2.3%
自由现金流更多
HCM
多$11.2M
$-7.8M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $270.8M | $140.7M |
| 净利润 | $2.0M | $-3.2M |
| 毛利率 | 37.7% | 41.9% |
| 营业利润率 | -13.2% | -1.6% |
| 净利率 | 0.7% | -2.3% |
| 营收同比 | -16.5% | 9.1% |
| 净利润同比 | -83.6% | 62.1% |
| 每股收益（稀释后） | $0.00 | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HCMPRPL
| Q4 25 | $270.8M | $140.7M | ||
| Q3 25 | — | $118.8M | ||
| Q2 25 | $277.7M | $105.1M | ||
| Q1 25 | $324.5M | $104.2M | ||
| Q4 24 | — | $129.0M | ||
| Q3 24 | — | $118.6M | ||
| Q2 24 | $305.7M | $120.3M | ||
| Q1 24 | — | $120.0M |
净利润HCMPRPL
| Q4 25 | $2.0M | $-3.2M | ||
| Q3 25 | — | $-11.7M | ||
| Q2 25 | $455.0M | $-17.3M | ||
| Q1 25 | $11.9M | $-19.1M | ||
| Q4 24 | — | $-8.5M | ||
| Q3 24 | — | $-39.2M | ||
| Q2 24 | $25.8M | $27.0K | ||
| Q1 24 | — | $-50.2M |
毛利率HCMPRPL
| Q4 25 | 37.7% | 41.9% | ||
| Q3 25 | — | 42.8% | ||
| Q2 25 | 0.1% | 35.9% | ||
| Q1 25 | 48.0% | 39.4% | ||
| Q4 24 | — | 42.9% | ||
| Q3 24 | — | 29.7% | ||
| Q2 24 | 41.1% | 40.7% | ||
| Q1 24 | — | 34.8% |
营业利润率HCMPRPL
| Q4 25 | -13.2% | -1.6% | ||
| Q3 25 | — | -10.2% | ||
| Q2 25 | -1.3% | -13.5% | ||
| Q1 25 | -5.0% | -13.9% | ||
| Q4 24 | — | -6.0% | ||
| Q3 24 | — | -39.5% | ||
| Q2 24 | -9.0% | -12.1% | ||
| Q1 24 | — | -19.3% |
净利率HCMPRPL
| Q4 25 | 0.7% | -2.3% | ||
| Q3 25 | — | -9.9% | ||
| Q2 25 | 163.8% | -16.5% | ||
| Q1 25 | 3.7% | -18.4% | ||
| Q4 24 | — | -6.6% | ||
| Q3 24 | — | -33.1% | ||
| Q2 24 | 8.4% | 0.0% | ||
| Q1 24 | — | -41.8% |
每股收益（稀释后）HCMPRPL
| Q4 25 | $0.00 | $0.03 | ||
| Q3 25 | — | $0.11 | ||
| Q2 25 | $0.52 | $0.16 | ||
| Q1 25 | $0.01 | $0.18 | ||
| Q4 24 | — | $0.08 | ||
| Q3 24 | — | $0.36 | ||
| Q2 24 | $0.03 | $0.00 | ||
| Q1 24 | — | $0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $24.3M |
| 总债务越低越好 | $93.2M | $126.7M |
| 股东权益账面价值 | $1.2B | $-29.7M |
| 总资产 | $1.8B | $296.3M |
| 负债/权益比越低杠杆越低 | 0.08× | — |
8季度趋势，按日历期对齐
现金及短期投资HCMPRPL
| Q4 25 | $1.4B | $24.3M | ||
| Q3 25 | — | $32.4M | ||
| Q2 25 | $1.4B | $34.2M | ||
| Q1 25 | $836.1M | $21.6M | ||
| Q4 24 | — | $29.0M | ||
| Q3 24 | — | $23.4M | ||
| Q2 24 | $802.5M | $23.4M | ||
| Q1 24 | — | $34.5M |
总债务HCMPRPL
| Q4 25 | $93.2M | $126.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | $70.7M | ||
| Q3 24 | — | $50.8M | ||
| Q2 24 | $82.1M | — | ||
| Q1 24 | — | — |
股东权益HCMPRPL
| Q4 25 | $1.2B | $-29.7M | ||
| Q3 25 | — | $-26.9M | ||
| Q2 25 | $1.2B | $-15.6M | ||
| Q1 25 | $759.9M | $1.3M | ||
| Q4 24 | — | $20.2M | ||
| Q3 24 | — | $28.0M | ||
| Q2 24 | $740.1M | $66.4M | ||
| Q1 24 | — | $65.5M |
总资产HCMPRPL
| Q4 25 | $1.8B | $296.3M | ||
| Q3 25 | — | $302.1M | ||
| Q2 25 | $1.8B | $303.8M | ||
| Q1 25 | $1.3B | $293.8M | ||
| Q4 24 | — | $307.8M | ||
| Q3 24 | — | $309.3M | ||
| Q2 24 | $1.3B | $362.1M | ||
| Q1 24 | — | $382.1M |
负债/权益比HCMPRPL
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | 3.50× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.2M | $-5.8M |
| 自由现金流经营现金流 - 资本支出 | $3.4M | $-7.8M |
| 自由现金流率自由现金流/营收 | 1.2% | -5.5% |
| 资本支出强度资本支出/营收 | 1.8% | 1.4% |
| 现金转化率经营现金流/净利润 | 4.21× | — |
| 过去12个月自由现金流最近4个季度 | $-96.2M | $-41.9M |
8季度趋势，按日历期对齐
经营现金流HCMPRPL
| Q4 25 | $8.2M | $-5.8M | ||
| Q3 25 | — | $-968.0K | ||
| Q2 25 | $-72.9M | $-4.0M | ||
| Q1 25 | $40.3M | $-23.1M | ||
| Q4 24 | — | $6.8M | ||
| Q3 24 | — | $1.1M | ||
| Q2 24 | $-39.8M | $-8.9M | ||
| Q1 24 | — | $-16.8M |
自由现金流HCMPRPL
| Q4 25 | $3.4M | $-7.8M | ||
| Q3 25 | — | $-1.8M | ||
| Q2 25 | $-82.2M | $-7.0M | ||
| Q1 25 | $32.5M | $-25.3M | ||
| Q4 24 | — | $5.7M | ||
| Q3 24 | — | $101.0K | ||
| Q2 24 | $-49.9M | $-11.0M | ||
| Q1 24 | — | $-19.9M |
自由现金流率HCMPRPL
| Q4 25 | 1.2% | -5.5% | ||
| Q3 25 | — | -1.5% | ||
| Q2 25 | -29.6% | -6.6% | ||
| Q1 25 | 10.0% | -24.3% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | -16.3% | -9.2% | ||
| Q1 24 | — | -16.5% |
资本支出强度HCMPRPL
| Q4 25 | 1.8% | 1.4% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | 3.3% | 2.8% | ||
| Q1 25 | 2.4% | 2.2% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | 3.3% | 1.7% | ||
| Q1 24 | — | 2.5% |
现金转化率HCMPRPL
| Q4 25 | 4.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.16× | — | ||
| Q1 25 | 3.38× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.54× | -330.22× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HCM
暂无分部数据
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
